Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88,500 | 218,300 | 475,900 | 287,400 | 269,200 |
| Receivables | 380,000 | 385,800 | 743,700 | 887,100 | 1,078,900 |
| Inventories | 1,683,100 | 1,551,500 | 1,949,300 | 1,973,800 | 2,171,400 |
| Other current assets | 251,000 | 278,800 | 452,800 | 1,197,700 | 457,300 |
| TOTAL | $2,402,600 | $2,434,400 | $3,621,700 | $4,346,000 | $3,976,800 |
| Non-Current Assets | |||||
| PPE Net | 754,400 | 729,700 | 1,240,200 | 1,253,000 | 1,437,200 |
| Investments And Advances | 45,800 | 42,200 | 0 | 0 | 0 |
| Intangibles | 4,344,200 | 4,202,900 | 6,521,100 | 6,787,000 | 6,793,000 |
| Other Non-Current Assets | 92,300 | 82,600 | 192,200 | 512,600 | 316,000 |
| TOTAL | $5,236,700 | $5,057,400 | $7,953,500 | $8,552,600 | $8,546,200 |
| Total Assets | $7,639,300 | $7,491,800 | $11,575,200 | $12,898,600 | $12,523,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 553,400 | 280,000 |
| Accounts payable and accrued liabilities | 162,600 | 206,100 | 399,500 | 426,200 | 486,800 |
| Other current liabilities | 471,700 | 524,200 | 827,000 | 721,400 | 851,700 |
| TOTAL | $966,700 | $758,700 | $1,646,000 | $2,004,800 | $1,675,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,612,200 | 1,902,100 | 2,320,600 | 3,290,100 | 3,671,300 |
| Other Non-Current Liabilities | 337,300 | 356,200 | 644,300 | 613,400 | 596,600 |
| TOTAL | $2,358,000 | $2,633,400 | $3,610,700 | $4,615,600 | $4,944,500 |
| Total Liabilities | $3,324,700 | $3,392,100 | $5,256,700 | $6,620,400 | $6,620,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 157,597 | 156,721 | 155,459 | 154,469 | 154,164 |
| Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 734,000 |
| Retained earnings | 5,935,600 | 5,892,600 | 8,202,200 | 7,849,300 | 7,550,400 |
| Other shareholders' equity | -184,400 | -299,300 | -350,200 | 18,800 | -28,600 |
| TOTAL | $4,314,600 | $4,099,700 | $6,318,500 | $6,278,200 | $5,902,600 |
| Total Liabilities And Equity | $7,639,300 | $7,491,800 | $11,575,200 | $12,898,600 | $12,523,000 |